Encompass Health Long Term Debt 2012-2025 | EHC
Encompass Health long term debt from 2012 to 2025. Long term debt can be defined as the sum of all long term debt fields.
- Encompass Health long term debt for the quarter ending December 31, 2025 was $2.394B, a 2.11% increase year-over-year.
- Encompass Health long term debt for 2024 was $2.359B, a 12.23% decline from 2023.
- Encompass Health long term debt for 2023 was $2.688B, a 1.97% decline from 2022.
- Encompass Health long term debt for 2022 was $2.742B, a 15.39% decline from 2021.
|
Encompass Health Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $2,359 |
| 2023 | $2,688 |
| 2022 | $2,742 |
| 2021 | $3,241 |
| 2020 | $3,251 |
| 2019 | $3,023 |
| 2018 | $2,479 |
| 2017 | $2,545 |
| 2016 | $2,979 |
| 2015 | $3,135 |
| 2014 | $2,090 |
| 2013 | $1,505 |
| 2012 | $1,240 |
| 2011 | $1,236 |
|
Encompass Health Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-09-30 | $2,394 |
| 2025-06-30 | $2,320 |
| 2025-03-31 | $2,333 |
| 2024-12-31 | $2,359 |
| 2024-09-30 | $2,345 |
| 2024-06-30 | $2,684 |
| 2024-03-31 | $2,683 |
| 2023-12-31 | $2,688 |
| 2023-09-30 | $2,693 |
| 2023-06-30 | $2,698 |
| 2023-03-31 | $2,723 |
| 2022-12-31 | $2,742 |
| 2022-09-30 | $2,719 |
| 2022-06-30 | $3,234 |
| 2022-03-31 | $3,221 |
| 2021-12-31 | $3,241 |
| 2021-09-30 | $3,142 |
| 2021-06-30 | $3,106 |
| 2021-03-31 | $3,160 |
| 2020-12-31 | $3,251 |
| 2020-09-30 | $3,539 |
| 2020-06-30 | $3,547 |
| 2020-03-31 | $3,322 |
| 2019-12-31 | $3,023 |
| 2019-09-30 | $2,962 |
| 2019-06-30 | $2,720 |
| 2019-03-31 | $2,522 |
| 2018-12-31 | $2,479 |
| 2018-09-30 | $2,504 |
| 2018-06-30 | $2,601 |
| 2018-03-31 | $2,544 |
| 2017-12-31 | $2,545 |
| 2017-09-30 | $2,591 |
| 2017-06-30 | $2,625 |
| 2017-03-31 | $2,916 |
| 2016-12-31 | $2,979 |
| 2016-09-30 | $2,974 |
| 2016-06-30 | $3,050 |
| 2016-03-31 | $3,080 |
| 2015-12-31 | $3,135 |
| 2015-09-30 | $2,801 |
| 2015-06-30 | $2,104 |
| 2015-03-31 | $2,123 |
| 2014-12-31 | $2,090 |
| 2014-09-30 | $1,441 |
| 2014-06-30 | $1,475 |
| 2014-03-31 | $1,503 |
| 2013-12-31 | $1,505 |
| 2013-09-30 | $1,306 |
| 2013-06-30 | $1,320 |
| 2013-03-31 | $1,365 |
| 2012-12-31 | $1,240 |
| 2012-09-30 | $1,242 |
| 2012-06-30 | $1,219 |
| 2012-03-31 | $1,246 |
| 2011-12-31 | $1,236 |
| 2011-09-30 | $1,309 |
| 2011-06-30 | $1,440 |
| 2011-03-31 | $1,551 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $11.082B | $5.935B |
| Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $34.042B | 17.17 |
| Quest Diagnostics (DGX) | United States | $23.013B | 21.00 |
| Elanco Animal Health (ELAN) | United States | $12.486B | 26.18 |
| DaVita (DVA) | United States | $9.950B | 13.72 |
| Chemed (CHE) | United States | $6.703B | 23.54 |
| Option Care Health (OPCH) | United States | $5.622B | 23.93 |
| RadNet (RDNT) | United States | $5.365B | 183.00 |
| LifeStance Health (LFST) | United States | $2.735B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.103B | 21.72 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.657B | 20.87 |
| U.S Physical Therapy (USPH) | United States | $1.322B | 33.44 |
| Pennant (PNTG) | United States | $1.106B | 36.75 |
| Astrana Health (ASTH) | United States | $1.057B | 98.84 |
| Daxor (DXR) | United States | $0.062B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.038B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |